Lesson plan
Esprolol
Esprolol, also known as (S)-ACC-9369, is a beta blocker which was under development for the treatment of angina pectoris, anxiety disorders, and migraine. It is taken sublingually and has a rapid onset of action, short time to peak, and short duration. The drug is a prodrug of amoxolol, which is formed from esprolol via esterase enzymes. It is a selective β 1 -adrenergic receptor antagonist. Esprolol was under development by Selectus Pharmaceuticals. It reached phase 2 clinical trials for all indications prior to the discontinuation of its development in 2001.
Article summary
Esprolol, also known as (S)-ACC-9369, is a beta blocker which was under development for the treatment of angina pectoris, anxiety disorders, and migraine. It is taken sublingually and has a rapid onset of action, short time to peak, and short duration. The drug is a prodrug of amoxolol, which is formed from esprolol via esterase enzymes. It is a selective β 1 -adrenergic receptor antagonist. Esprolol was under development by Selectus Pharmaceuticals. It reached phase 2 clinical trials for all indications prior to the discontinuation of its development in 2001.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.